165 related articles for article (PubMed ID: 18700152)
1. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products.
Woodward DF; Carling RW; Cornell CL; Fliri HG; Martos JL; Pettit SN; Liang Y; Wang JW
Pharmacol Ther; 2008 Oct; 120(1):71-80. PubMed ID: 18700152
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases.
Urquhart P; Nicolaou A; Woodward DF
Biochim Biophys Acta; 2015 Apr; 1851(4):366-76. PubMed ID: 25543004
[TBL] [Abstract][Full Text] [Related]
3. Prostamides (prostaglandin-ethanolamides) and their pharmacology.
Woodward DF; Liang Y; Krauss AH
Br J Pharmacol; 2008 Feb; 153(3):410-9. PubMed ID: 17721551
[TBL] [Abstract][Full Text] [Related]
4. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
Woodward DF; Krauss AH; Wang JW; Protzman CE; Nieves AL; Liang Y; Donde Y; Burk RM; Landsverk K; Struble C
Br J Pharmacol; 2007 Feb; 150(3):342-52. PubMed ID: 17179945
[TBL] [Abstract][Full Text] [Related]
5. Psychopharmacology of the endocannabinoids: far beyond anandamide.
Pamplona FA; Takahashi RN
J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.
Matias I; Chen J; De Petrocellis L; Bisogno T; Ligresti A; Fezza F; Krauss AH; Shi L; Protzman CE; Li C; Liang Y; Nieves AL; Kedzie KM; Burk RM; Di Marzo V; Woodward DF
J Pharmacol Exp Ther; 2004 May; 309(2):745-57. PubMed ID: 14757851
[TBL] [Abstract][Full Text] [Related]
7. COX-2-derived endocannabinoid metabolites as novel inflammatory mediators.
Alhouayek M; Muccioli GG
Trends Pharmacol Sci; 2014 Jun; 35(6):284-92. PubMed ID: 24684963
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides.
Kozak KR; Crews BC; Morrow JD; Wang LH; Ma YH; Weinander R; Jakobsson PJ; Marnett LJ
J Biol Chem; 2002 Nov; 277(47):44877-85. PubMed ID: 12244105
[TBL] [Abstract][Full Text] [Related]
9. A historical perspective and recent advances in prostamide research and therapeutics.
Burk RM; Woodward DF
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):413-21. PubMed ID: 17659482
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin ethanolamides attenuate damage in a human explant colitis model.
Nicotra LL; Vu M; Harvey BS; Smid SD
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():22-9. PubMed ID: 23380599
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics.
Woodward DF; Wang JW; Poloso NJ
Pharmacol Rev; 2013; 65(4):1135-47. PubMed ID: 23893067
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes.
Van Dross RT
Mol Carcinog; 2009 Aug; 48(8):724-32. PubMed ID: 19148897
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2-Glyceryl Ester: In Vivo Evidence for a Distinct Pharmacological Identity from Intraocular Pressure Studies.
Woodward DF; Poloso NJ; Wang JW
J Pharmacol Exp Ther; 2016 Aug; 358(2):173-80. PubMed ID: 27217589
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2.
Yang W; Ni J; Woodward DF; Tang-Liu DD; Ling KH
J Lipid Res; 2005 Dec; 46(12):2745-51. PubMed ID: 16150817
[TBL] [Abstract][Full Text] [Related]
15. Assay of Endocannabinoid Oxidation by Cyclooxygenase-2.
Kudalkar SN; Kingsley PJ; Marnett LJ
Methods Mol Biol; 2016; 1412():205-15. PubMed ID: 27245906
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
17. Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).
Correa F; Docagne F; Clemente D; Mestre L; Becker C; Guaza C
Biochem J; 2008 Feb; 409(3):761-70. PubMed ID: 17961121
[TBL] [Abstract][Full Text] [Related]
18. Aspects of Prostaglandin Glycerol Ester Biology.
Kingsley PJ; Rouzer CA; Morgan AJ; Patel S; Marnett LJ
Adv Exp Med Biol; 2019; 1161():77-88. PubMed ID: 31562623
[TBL] [Abstract][Full Text] [Related]
19. Analysis of endocannabinoids, their congeners and COX-2 metabolites.
Kingsley PJ; Marnett LJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2746-54. PubMed ID: 19505857
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo.
Kozak KR; Crews BC; Ray JL; Tai HH; Morrow JD; Marnett LJ
J Biol Chem; 2001 Oct; 276(40):36993-8. PubMed ID: 11447235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
